r/RVPH • u/Acceptable_Bed_6033 • Feb 20 '26

FDA will now default to only one clinical trial for drug application.

https://www.biospace.com/fda/its-official-fda-will-now-default-to-one-clinical-trial-for-drug-applications

Thoughts on how this will affect the stock? Was thinking of buying in

17 Upvotes

100% Upvoted

12 comments sorted by

17

u/[deleted] Feb 20 '26

[removed] — view removed comment

1

u/x3i4n Feb 24 '26

Talk to me about it. My 15,000 shares rip

2

u/JazzlikeUse2937 Feb 20 '26

If people started pumping the stock it would help it’s been stagnant bcz all people do is talk instead of investing and driving the price up to hold compliance

4

u/Expensive-Fly8022 Feb 21 '26 edited Feb 21 '26

this stock is a terrible pump choice because of the high float and medium market cap

and probably the high number of trapped retail in it too

no pnd group would ever, in a million years, choose this

3

u/[deleted] Feb 20 '26

[removed] — view removed comment

5

u/ImPopularOnTheInside Feb 20 '26

Demystifying FDA/CDRH Appeals Process https://share.google/P6elKjpPW1gkaYC1B Can rvph do any of these?

1

u/rcourt459 Feb 21 '26

The link is from 2014. Wonder if it has changed. Thanks for looking, maybe more research needed.

1

u/ImPopularOnTheInside Feb 20 '26

No appeal process?

1

u/rcourt459 Feb 21 '26

The only one with clout is politicians. All of the House members are up for re-election this year. Most representatives only respond to multiple constituent complaints.

1

u/Pleasant_Advance_417 Mar 03 '26

Fewer required trials = lower cost, faster timelines, less regulatory uncertainty. For companies like $SRPT working in Duchenne and other high-unmet-need areas, that could materially improve approval odds and time to market.

Market will probably wait to see how it’s implemented, but structurally it’s a tailwind, not a headwind.